滋肾健脾调冲汤联合来曲唑治疗多囊卵巢综合征临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.75

基金项目:

温州市基础性公益科研项目(Y20220403)


Clinical Study on Treatment of Polycystic Ovary Syndrome with Zishen Jianpi Tiaochong Decoction Combined with Letrozole
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察滋肾健脾调冲汤联合来曲唑治疗多囊卵巢综合征的疗效。方法:选取2022年5月— 2023年5月温州市人民医院收治的120例多囊卵巢综合征患者,均已行屈螺酮炔雌醇预处理至性激素水平复 常,按数字抽签法分为中药组、西药组、联合组各40例,中药组给予滋肾健脾调冲汤治疗,西药组给予来曲 唑治疗,联合组给予滋肾健脾调冲汤联合来曲唑治疗。比较3组治疗前后优势卵泡最长径、卵巢体积、子宫内 膜厚度的变化,比较3组排卵率、妊娠率及不良反应发生率。结果:治疗后,3组优势卵泡最长径、子宫内膜 厚度均较治疗前增加(P<0.05),卵巢体积均较治疗前减小(P<0.05);联合组优势卵泡最长径、子宫内膜厚 度均高于中药组、西药组(P<0.05), 卵巢体积小于中药组、西药组(P<0.05)。联合组排卵率为 85.00% (34/40),高于中药组排卵率57.50% (23/40) 及西药组排卵率65.00% (26/40),差异有统计学意 义(P<0.05)。联合组妊娠率45.00%(18/40),高于中药组妊娠率17.50%(7/40) 及西药组妊娠率22.50%(9/ 40),差异有统计学意义(P<0.05),西药组不良反应发生率为25.00%(10/40),高于中药组不良反应发生率 5.00%(2/40) 及联合组不良反应发生率12.50%(5/40),差异有统计学意义(P<0.05)。结论:多囊卵巢综合 征患者经屈螺酮炔雌醇预处理后采用滋肾健脾调冲汤联合来曲唑治疗,可改善卵巢形态,增加子宫内膜厚度, 促进排卵,提高妊娠率,安全性高。

    Abstract:

    Abstract: Objective: To observe the therapeutic effects of Zishen Jianpi Tiaochong Decoction combined with Letrozole in the treatment of polycystic ovary syndrome (PCOS). Methods:A total of 120 patients with PCOS treated at Wenzhou People's Hospital from May 2022 to May 2023 were selected. All patients had undergone Drospirenone- Ethinylestradiol pretreatment to normalize their sex hormone levels. They were divided into three groups (40 cases each) using a numerical lottery method: the Chinese medicine group, the western medicine group, and the combination group. The Chinese medicine group was treated with Zishen Jianpi Tiaochong Decoction, the western medicine group with Letrozole,and the combination group with both Zishen Jianpi Tiaochong Decoction and Letrozole. The changes in the longest diameter of dominant follicles,ovarian volume,and endometrial thickness were compared before and after treatment among the three groups. Additionally, ovulation rates, pregnancy rates, and the incidence of adverse reactions were compared. Results: After treatment, the longest diameter of dominant follicles and endometrial thickness were increased significantly in all three groups (P<0.05), while ovarian volume were decreased significantly (P<0.05). The combination group showed a greater increase in the longest diameter of dominant follicles and endometrial thickness compared to the Chinese medicine and western medicine groups (P<0.05),and a smaller ovarian volume (P<0.05). The ovulation rate in the combination group was 85.00% (34/40),higher than that in the Chinese medicine group (57.50%, 23/40) and the western medicine group (65.00%, 26/40) (P<0.05). The pregnancy rate in the combination group was 45.00% (18/40), higher than that in the Chinese medicine group (17.50%, 7/40) and the western medicine group (22.50%, 9/40) (P<0.05). The incidence of adverse reactions was 25.00%( 10/40) in the western medicine group,higher than that in the Chinese medicine group( 5.00%, 2/40) and the combination group (12.50%, 5/40) (P<0.05). Conclusion: For patients with polycystic ovary syndrome who have undergone Drospirenone-Ethinylestradiol pretreatment,the combination of Zishen Jianpi Tiaochong Decoction and Letrozole can improve ovarian morphology, increase endometrial thickness, promote ovulation, and enhance the probability of successful pregnancy,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

金培培,吴安乐,杨洋,温新特,林友宝,陈文跃.滋肾健脾调冲汤联合来曲唑治疗多囊卵巢综合征临床研究[J].新中医,2025,57(11):84-88

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-13
  • 出版日期:
文章二维码